KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 61 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $3,169,000 | -61.3% | 300,987 | 0.0% | 0.51% | -53.5% |
| Q2 2015 | $8,190,000 | -11.1% | 300,987 | 0.0% | 1.09% | -23.5% |
| Q1 2015 | $9,213,000 | -36.1% | 300,987 | -21.8% | 1.42% | -35.9% |
| Q4 2014 | $14,411,000 | +7.1% | 385,000 | 0.0% | 2.22% | -19.7% |
| Q3 2014 | $13,452,000 | -24.9% | 385,000 | 0.0% | 2.77% | -41.7% |
| Q2 2014 | $17,922,000 | +107.2% | 385,000 | +37.5% | 4.75% | +138.8% |
| Q1 2014 | $8,649,000 | +277.4% | 280,000 | +180.0% | 1.99% | +199.1% |
| Q4 2013 | $2,292,000 | – | 100,000 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |